Global Clinical Trial Supply & Logistics Market Projects Strong Growth with Advanced Services and Biologic Drugs Driving Demand

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2023-2030" report has been added to's offering.

Expanding at a Remarkable CAGR, the Clinical Trial Supply & Logistics Market Forecasts a Significant Upsurge by 2030

The Clinical Trial Supply & Logistics Market is set to witness formidable growth, according to a newly compiled research publication. The market, highly responsive to the surging demand for comparator sourcing, logistics & distribution, and manufacturing services, is expected to advance at a Compound Annual Growth Rate (CAGR) of 7.74%, burgeoning from USD 24.33 billion in 2023 to an estimated USD 41.04 billion by 2030.

The research offers nuanced insights into the proliferating necessities of biologic drugs, medical devices, and small molecules across multifarious clinical trial phases. The meticulous attention given to therapeutic areas including oncology, CNS & mental disorders, among others, signifies how the market is evolving to accommodate diverse clinical needs.

Regional Spectrum of Clinical Trial Supply & Logistics Market

Emerging atop the Global Clinical Trial Supply & Logistics scene is the Americas, with North America, particularly the United States, being a hotbed for pharmaceutical R&D investment. Asia-Pacific regions are gaining momentum owing to thriving pharmaceutical landscapes, with countries like China and India demonstrating robust growth in clinical trial activities. Europe continues to be a vital player, bolstered by stringent regulations ensuring the quality of clinical trial supplies.

Targeted Evaluation through FPNV Positioning Matrix

The disclosure further includes a thorough assessment through the FPNV Positioning Matrix, categorizing vendors based on business strategy excellence and product satisfaction. Enhanced understanding of the vendor landscape facilitates informed decision-making for stakeholders and contributes to the strategic direction of the market.

Incorporating Market Share Analysis

Complementary to competitor analysis, the Market Share Analysis segment of the report offers a detailed scrutiny of vendors' impact on the market. It helps companies grasp the competitive distribution and guides them to refine their strategies for a tangible market presence.

Insightful Profiles of Key Companies

The research orbits around the market's major players, dissecting recent developments and offering a horizon of strategic endeavors in the sector. Company profiles in the research include top-tier entities that are steering the course of clinical trial supply and logistics globally.

Market Segmentation & Coverage

An exhaustive segmentation analysis is the cornerstone of the research, covering:

  • Services: Comparator Sourcing, Logistics & Distribution, Cold Chain Distribution, Non-Cold Chain Distribution, Manufacturing, Packaging, Labeling, & Blinding, Storage & Retention
  • Type: Biologic Drugs, Medical Devices, Small Molecules
  • Phase: BA/ BE studies, Phase 1 through Phase 4
  • Therapeutic Area: From Blood Disorders to Rare Diseases
  • End User: CROs, Medical Devices Companies, Pharmaceutical & Biotechnology companies
  • Region: Geographical analysis spanning the Americas, Asia-Pacific, Europe, Middle East & Africa

The report's findings spotlight strategic dynamics within the market and reveal critical trajectories for growth, shaping the future of the Clinical Trial Supply & Logistics landscape.

Dedicated to equipping stakeholders with an actionable roadmap, the report addresses sensitive questions related to market size and forecasts, product developments, technology trends, regulatory frameworks, competitive intelligence, market penetration, and diversification strategies. It's poised to be an invaluable resource for industry players worldwide.

With the market's acceleration influenced by increasing investment in healthcare infrastructure and a surge in global demand for advanced clinical trial services, the Clinical Trial Supply & Logistics domain stands on the precipice of a new era of growth and innovation.

Key Attributes

Report AttributeDetails
No. of Pages184
Forecast Period2023 - 2030
Estimated Market Value (USD) in 2023$24.33 Billion
Forecasted Market Value (USD) by 2030$41.04 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal

Companies Mentioned

  • Almac Group
  • Ancillare, LP
  • Beroe Holdings Inc.
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • Deutsche Post AG
  • Eurofins Scientific Group
  • Inceptua S.A.
  • Infosys Limited
  • Liveo Research GmbH
  • Lonza Group AG
  • Marken Limited
  • Myonex, Inc.
  • Octalsoft
  • Parexel International Corporation
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH & Co KG
  • Piramal Pharma Solutions
  • SAP SE
  • Signant Health
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.
  • Walden Group

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Clinical Trial Supply & Logistics Market